Prevention of complications after inferior myocardial infarction treated by using percutaneous coronary intervention – case report

Petru Bălăceanu, Nicoleta Dima, Mariana Floria, Madalina Ionela Chiriac, Alexandru Mărian, Ciprian Rezuş


We present the case of a 59 year-old female diagnosed with hypertension and dyslipidemia, who had previously suffered an inferior myocardial infarction, treated by using percutaneous coronary intervention (PCI). The patient subsequently developed hypertensive encephalopathy phenomena, due to an episode of respiratory infection. The hypertensive encephalopathy is a complex clinical entity that requires quick acknowledgment and proper management in order to decrease the high mortality rate. The diagnostic delay would lead to a negative prognosis for the patient, through the development of brain lesions, often irreversible.


hypertension, hypertensive encephalopathy, myocardial infarction, atherosclerosis

Full Text:



Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL. Harrison's Principles of Internal Medicine, 16th edition. New York: McGraw-Hill Medical Publishing Division, 2005.

Aeschbacher BC, Hutter D, Fuhrer J, et al. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001; 14(2):106-13.

Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358:1305-1315.

Lewis EF, Moye LA, Rouleau JL, Sacks FM, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol 2003; 42:446-1453.

Richards AM, Nicholls MG, Troughton RW, Lainchbury JG, et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39:1182-1188.

Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291:1071-80.

Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high intensity statin therapy on regression of coronary atherosclerosis. The ASTEROID trial. JAMA 2006; 295:1556-65.

Task Force Members, Montalescot G, Sechtem U, et al. ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013; 34:2949-3003.

Task Force Members, Mancia G, Fagard R, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34:2159-2219.

Gueyffier F, Bulpit C, Boissel JP, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. Lancet 1999; 353(9155):793-6.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349):1903-13.


Copyright (c)

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975